Basics Tarsus Pharmaceuticals, Inc. Common Stock IPO Date: October 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $3.47B Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 2.70% Avg Daily Range (30 D): $1.45 | 1.98% Avg Daily Range (90 D): $1.26 | 2.06% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .36M Avg Daily Volume (90 D): .5M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 37 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 1,406 Avg Inst. Trade: $2.76M Avg Inst. Trade (30 D): $3.01M Avg Inst. Trade (90 D): $3.06M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.98M Avg Closing Trade (30 D): $3.69M Avg Closing Trade (90 D): $4.27M Avg Closing Volume: 77.12K     News Oct 28, 2025 @ 9:00 PM Tarsus to Report Third Quarter 2025 Financial Resu... Source: Tarsus Pharmaceuticals, Inc. Oct 27, 2025 @ 3:15 PM Capricorn Fund Loads Up on Phreesia (PHR) With a 4... Source: Cory Renauer Oct 1, 2025 @ 5:00 PM Lyme Disease Market Growth Highlighted by Pipeline... Source: Delveinsight Aug 27, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Tarsus Pharmaceuticals, Inc. Aug 27, 2025 @ 8:26 AM 3 Biotech Catalysts Present Major Opportunity Source: Nathan Reiff Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.3 $-.48 $-.64 Diluted EPS $-.3 $-.48 $-.64 Revenue $ 118.7M $ 102.66M $ 78.34M Gross Profit $ $ $ Net Income / Loss $ -12.59M $ -20.34M $ -25.12M Operating Income / Loss $ -14.53M $ -22.18M $ -26.28M Cost of Revenue $ $ $ Net Cash Flow $ 16.08M $ -79.14M $ 80.97M PE Ratio